Suzuki Hitoshi

Affiliation and department：

Research field (1)： Nephrology

Papers (100)：

Yoko Shirai, Kenichiro Miura, Tomoo Yabuuchi, Takeshi Nagasawa, Kiyonobu Ishizuka, Kazuhiro Takahashi, Sekiko Taneda, Kazuho Honda, Yutaka Yamaguchi, Hitoshi Suzuki, et al. Rapid progression to end-stage renal disease in a child with IgA-dominant infection-related glomerulonephritis associated with parvovirus B19. CEN case reports. 2020
Akiko Takahata, Satoko Arai, Emiri Hiramoto, Kento Kitada, Rina Kato, Yuko Makita, Hitoshi Suzuki, Junichiro Nakata, Kimi Araki, Toru Miyazaki, et al. Crucial Role of AIM/CD5L in the Development of Glomerular Inflammation in IgA Nephropathy. Journal of the American Society of Nephrology : JASN. 2020
Koshi Yamada, Zhi Qiang Huang, Milan Raska, Colin Reily, Joshua C Anderson, Hitoshi Suzuki, Krzysztof Kiryluk, Ali G Gharavi, Bruce A Julian, Christopher D Willey, et al. Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy. Kidney diseases (Basel, Switzerland). 2020. 6. 3. 168-180
深尾勇輔, 鈴木仁, 牧田侑子, 狩野俊樹, 鈴木祐介. IgA腎症における扁桃摘出術単独と扁摘パルス療法の比較検証. 日本内科学会雑誌. 2020. 109. Suppl. 205-205
Yuko Makita, Hitoshi Suzuki, Toshiki Kano, Akiko Takahata, Bruce A Julian, Jan Novak, Yusuke Suzuki. TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-mediated pathways in IgA nephropathy. Kidney international. 2020. 97. 2. 340-349

ｍore...

MISC (109)：

ｍore...

Patents (3)：

Lectures and oral presentations (73)：

Symposium ‘Advances in Renal Pathology’ Pathogenesis of IgA nephropathy
(18th Asian Pacific Congress of Nephrology 2020)
【シンポジウム「日本人の腎臓病特性と病態」】日本人のIgA腎症診療~国際比較~
(第50回日本腎臓学会東部学術大会 2020)
【シンポジウム「糸球体疾患に対する生物学的製剤の可能性と問題点-Current and Future Indications-」】IgA腎症に対する生物学的製剤治療の可能性
(第63回日本腎臓学会学術総会 2020)
IgA腎症において扁桃摘出術にステロイドパルス療法を併用する意義
(第43回IgA腎症研究会学術集会プログラム 2020)
日本人コホートにおける国際IgA腎症予後予測モデルの有用性の検討
(第43回IgA腎症研究会学術集会プログラム 2020)

ｍore...

Awards (3)：

2017/05 - Clinical Scientist Award Multi-Hit Pathogenetic Pathways in IgA Nephropathy
2016/06 - 第59回日本腎臓学会学術総会優秀演題賞 IgA腎症における腎糸球体糖鎖異常IgA1の検証
2006/10 - Berger Award Epstein-Barr Virus (EBV)-immortalized B Cells from Patients with IgA Nephropathy (IgAN) Secrete IgA1 with Galactose (Gal)-deficient O-linked Glycans

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page